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Abstract
Background—Posttraumatic stress disorder (PTSD) is a heterogeneous construct, and some 
have suggested that PTSD triggered by acute coronary syndrome (ACS) may differ from PTSD 
due to prototypical traumas.
Methods—We conducted the first examination of the latent structure of PTSD symptoms after 
suspected ACS in 399 adults in the REactions to Acute Care and Hospitalization (REACH) study, 
an observational cohort study of patients recruited from the emergency department during 
evaluation for ACS. Using confirmatory factor analysis, we compared the 4-factor dysphoria, 4-
factor numbing, and 5-factor dysphoric arousal models of PTSD.
Results—Although all models fit well, the dysphoria model was selected as the best-fitting 
model. Further, there was measurement invariance of the dysphoria model by sex. PTSD 
dimensions evidenced differential associations with indicators of threat perception during ACS 
evaluation and adherence to cardioprotective medication.
Limitations—One limitation of this investigation is the use of self-report measures. In addition, 
only one-third of the sample was diagnosed with ACS at discharge; the remaining participants 
*Corresponding author: Jennifer A. Sumner, Columbia University Mailman School of Public Health, Department of Epidemiology, 
722 W.168th St, Room 720H, New York, NY 10032 Phone: 212-342-0401; Fax: 212-342-5168; js4456@cumc.columbia.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
J Affect Disord. Author manuscript; available in PMC 2016 November 01.
Published in final edited form as:









received diagnoses such as chest pain without a cardiac diagnosis, another symptom/disease 
process (e.g., hypertensive chronic kidney disease), or another cardiac disease.
Conclusions—Findings suggest that suspected ACS-related PTSD symptoms are best-
represented by a 4-factor structure distinguishing between specific (e.g., re-experiencing) and non-
specific (dysphoria) symptoms of PTSD that has received support in the broader PTSD literature.
Keywords
Posttraumatic stress disorder; acute coronary syndrome; latent structure; confirmatory factor 
analysis
1. Introduction
Unlike most psychiatric disorders, posttraumatic stress disorder (PTSD) is contingent upon 
exposure to a traumatic event [American Psychiatric Association (APA), 2013]. In recent 
years, PTSD that develops in response to acute life-threatening medical events, such as acute 
coronary syndrome (ACS), has received increasing attention as an important public health 
concern (see Edmondson, 2014, for a review). ACS encompasses a variety of conditions in 
which the blood supply to the heart is suddenly blocked, including acute myocardial 
infarction and unstable angina (Ruff and Braunwald, 2011), and over 1 million individuals 
are hospitalized in the United States each year for ACS (Mozaffarian et al., 2015). ACS 
patients frequently report peritraumatic experiences that are associated with risk for 
developing PTSD, including intense fear, perceived life threat, helplessness, and a lack of 
control (Edmondson, 2014; Holbrook et al., 2001). Meta-analytic evidence suggests that 
PTSD due to ACS is common, with approximately 12% of individuals developing 
significant PTSD symptoms in response to ACS (Edmondson et al., 2012). Moreover, 
elevated ACS-related PTSD symptoms have been associated with double the risk of ACS 
recurrence and all-cause mortality (Edmondson et al., 2012), as well as with lower 
adherence to recommended health behaviors, such as adherence to cardiovascular 
medications (Kronish, Edmondson et al., 2012).
Although PTSD has often been treated as a homogeneous diagnostic entity, a well-
established literature indicates that this disorder is a heterogeneous construct (Forbes et al., 
2010; Zoellner et al., 2014). A growing body of factor analytic studies has supported 4- and 
5-factor models of PTSD symptoms. The 4-factor dysphoria model has factors for re-
experiencing, avoidance, hyperarousal, and dysphoria symptoms, with the dysphoria factor 
defined by symptoms reflecting non-specific aspects of emotional disorders, such as 
insomnia and irritability (Simms et al., 2002). The 4-factor numbing model separates 
avoidance and emotional numbing symptoms into distinct factors, resulting in re-
experiencing, avoidance, numbing, and hyperarousal factors (King et al., 1998). The main 
distinction between these models is whether three hyperarousal items, namely sleep 
disturbance, irritability/anger, and difficulty concentrating, are indicators of dysphoria (as in 
the dysphoria model) or hyperarousal (as in the numbing model). Meta-analytic evidence 
suggests that both 4-factor models characterize PTSD symptoms well (Yufik and Simms, 
2010), and this work influenced the number of symptom clusters included in the revised 
PTSD diagnosis for the fifth edition of the Diagnostic and Statistical Manual of Mental 
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Disorders (DSM-5; APA, 2013). Indeed, the DSM-5 PTSD criteria include a 4-factor model 
of symptoms that is most similar to the numbing model. A 5-factor dysphoric arousal model 
has also been developed that separates hyperarousal symptoms into those reflecting 
dysphoric arousal (i.e., symptoms of agitation and restlessness) and anxious arousal (i.e., 
fear-based arousal symptoms), resulting in re-experiencing, avoidance, numbing, dysphoric 
arousal, and anxious arousal factors (Elhai et al., 2011). The dysphoric arousal model has 
been found to be superior to the two 4-factor models in several samples (e.g., Armour et al., 
2013; Harpaz-Rotem et al., 2014; Pietrzak et al., 2012).
Studying the measurement invariance of PTSD symptom structure is important because it 
can indicate whether model features remain stable as a function of clinically-relevant 
factors, such as sample characteristics (e.g., age; Sumner et al., 2014) or conditions 
(endorsement of the subjective fear/helplessness/horror Criterion A2; Armour, Layne et al., 
2011). In the broader literature, PTSD symptoms have been found to be more common and 
severe in women than in men (Kessler et al., 1995; Tolin and Foa, 2006), and several studies 
have examined sex differences in the factor structure of PTSD symptoms (e.g., Armour, 
Elhai et al., 2011; Hall et al., 2012; Sumner et al., 2014; Wang et al., 2013). Although there 
is variability in the degree of support for measurement invariance in the dysphoria, numbing, 
and dysphoric arousal models of PTSD symptoms across sex, a number of investigations 
have documented higher item intercepts and/or factor means (suggestive of greater PTSD 
severity) for female than male participants (Armour, Elhai et al., 2011; Sumner et al., 2014; 
Wang et al., 2013; although see Hall et al., 2012, for an exception).
In addition, it is of interest to examine correlates of PTSD symptom dimensions. Indeed, 
researchers have emphasized the importance of validating distinct PTSD dimensions against 
functional correlates rather than solely relying on model fit statistics (Elhai and Palmieri, 
2011). Accordingly, evidence of differential associations between symptom dimensions of 
the dysphoric arousal model with neurobiological correlates of PTSD (e.g., serotonergic 
receptor density and norepinephrine transporter availability in the brain; Pietrzak, Gallezot 
et al., 2013; Pietrzak, Henry et al., 2013) suggests that studying PTSD symptom dimensions 
may help to refine understanding of how underlying factors relate to manifestations of the 
PTSD phenotype.
Despite extensive research on the dimensional structure of PTSD in veterans (e.g., Harpaz-
Rotem et al., 2014; Pietrzak et al., 2012) and nationally representative samples exposed to a 
variety of traumas (Armour et al., 2013), to date, no study of which we are aware has 
examined the latent structure of PTSD symptoms that develop in response to ACS. 
Elucidating the dimensions underlying this disorder can further the understanding of 
manifestations of PTSD symptoms induced by ACS. Some researchers have hypothesized 
that PTSD triggered by discrete external traumatic events such as combat exposure and 
physical assault is distinct from PTSD triggered by acute manifestations of chronic disease 
due, in part, to differences in the nature of certain PTSD symptoms. For example, the re-
experiencing symptoms of individuals with PTSD triggered by an acute presentation of a 
chronic illness may be focused on enduring threats of recurrence and functional decline as 
opposed to a discrete past event (Edmondson, 2014). Tests of whether the latent structure of 
PTSD induced by ACS is similar to that of PTSD that develops in response to other types of 
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traumatic events can help to address whether PTSD due to acute illness best fits within the 
traditional PTSD framework. Furthermore, delineating how dimensions of ACS-related 
PTSD symptoms relate to clinically-relevant factors, and demonstrating evidence of 
differential associations, can refine understanding and improve knowledge of mechanisms of 
risk of the development of and consequences from PTSD.
In this study, we conducted the first known evaluation of the dimensional structure of PTSD 
symptoms after suspected ACS using data from the REactions to Acute Care and 
Hospitalization (REACH) study, an observational cohort study of emergency department 
(ED) predictors of medical and psychological outcomes after evaluation for ACS. Using 
confirmatory factor analysis (CFA), we compared the 4-factor dysphoria, the 4-factor 
numbing, and the 5-factor dysphoric arousal models. In addition, we tested for measurement 
invariance of the best-fitting model across sex. Furthermore, we examined predictors and 
correlates of PTSD symptom dimensions after suspected ACS, namely perceived life threat 
and personal vulnerability in the ED (a risk factor for developing PTSD; Holbrook et al., 
2001), and aspirin adherence one month after ACS evaluation (a functional correlate with 
relevance to cardiovascular health outcomes; Kronish, Edmondson et al., 2012).
2. Methods
2.1 Participants and Procedure
The REACH study is an ongoing observational cohort study of patients recruited during 
evaluation for ACS at the New York-Presbyterian Hospital ED. Patients were included if the 
treating ED physician indicated they had “probable ACS.” Patients were excluded if they 
had ST elevations on their electrocardiogram, as this triggers a rapid emergency protocol 
and transfer to the cardiac catheterization laboratory such that enrollment in the ED was not 
possible. Patients were also excluded from participation if they were deemed unable to 
comply with the protocol (e.g., due to dementia or substance abuse), were deemed in need of 
immediate psychiatric intervention, or were unavailable for follow-up (e.g., due to terminal 
non-cardiovascular illness). In the ED, participants completed measures of their ED 
experience, including perceived life threat and personal vulnerability in response to the acute 
cardiac event that brought them to the hospital. Diagnosis at discharge was determined by 
review of the medical record by a board-certified cardiologist. Approximately one month 
after ED enrollment, participants completed a follow-up phone interview that assessed 
PTSD symptoms that developed in response to the “heart problem, ED visit, and 
hospitalization” that occurred when they enrolled in the study. Adherence to aspirin 
medication in the past month was also assessed via self-report at this follow-up assessment.
Of those deemed eligible for the REACH study, 75% enrolled, and the participant retention 
rate for the one-month follow-up assessment has been 93%. The analytic sample for the 
current study comprised 399 individuals who completed the one-month follow-up 
assessment. Participant characteristics are presented in Table 1. All participants provided 
informed consent. The study was approved by the Institutional Review Board at the 
Columbia University Medical Center and conducted in accordance with the Helsinki 
Declaration as revised in 1989.
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2.2.1 Perceived Life Threat and Personal Vulnerability—We assessed participants’ 
perceptions of life threat and personal vulnerability in response to the acute cardiac event in 
the ED with 12 items (e.g., “I am in pain,” “I am afraid,” “I feel helpless,” “I feel 
vulnerable,” “I worry that I am not in control of my situation”) based on Ozer et al. (2003). 
Patients rated the extent to which these statements reflected their experience in the ED on a 
4-point Likert scale ranging from “Not at all” to “Extremely.” Responses to these items had 
good internal consistency (Cronbach’s α=.79). Previous research (e.g., Wiedemar et al., 
2008) has utilized similar items to assess perceived vulnerability after acute cardiovascular 
events.
2.2.2 PTSD Symptoms in Response to Suspected ACS—PTSD symptoms were 
assessed at one-month follow-up with the PTSD Checklist for a Specific Stressful 
Experience (PCL-S; Weathers et al., 1993), a PTSD screening instrument developed by the 
National Center for PTSD that assesses the degree to which individuals are bothered by the 
17 DSM-IV diagnostic criteria for PTSD (APA, 2000). Participants rated the extent to which 
they were bothered by PTSD symptoms in the past month in response to the heart problem, 
emergency room visit, and hospitalization that occurred one month ago when they enrolled 
in the study. Responses were rated on a scale from 1 (“Not at all”) to 5 (“Extremely”). 
Internal consistency of the PCL-S in the current sample was excellent (Cronbach’s α=.92). 
Prior research has demonstrated that the PCL is a reliable and valid measure of PTSD (e.g., 
Blanchard et al., 1996; Weathers et al., 1993). DSM-IV PTSD symptoms were assessed in 
the current study, as the study was started prior to the publication of DSM 5. PCL-S items 
were used as indicators in the confirmatory factor analyses. However, for descriptive 
purposes, we report the percentage of the sample with probable PTSD based on a cut-off 
score of 35 or greater on the PCL-S, as has been suggested for civilian medical settings (VA 
National Center for PTSD, 2012).
2.2.3 Aspirin Adherence—Post-discharge aspirin adherence was assessed at the one-
month follow-up interview
Participants were asked if their doctor recommended that they take aspirin. If participants 
reported that their doctor had prescribed aspirin, they then were asked to indicate how often 
they took their aspirin as recommended in the past month. Responses were made on a 0–5 
scale that ranged from “Less than half the time (<50%)” to “All the time (100%).” 
Adherence was dichotomized as being 100% adherent or not (Cutter et al., 1991; Gehi et al., 
2005).
2.3 Data Analysis
Analyses proceeded in three steps. First, we compared structural models of suspected ACS-
related PTSD symptoms using CFAs conducted with Mplus version 6.11 (Muthén and 
Muthén, 1998–2010); Table 2 shows item mappings of all of the models evaluated in this 
study. The PCL-S items were treated as ordinal variables, and a robust (mean- and variance-
adjusted) method of weighted least squares estimation (WLSMV; Muthén and Muthén, 
1998–2010) was used. The WLSMV estimator in Mplus invokes a polychoric correlation 
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matrix, and probit coefficients for the factor loadings are estimated (Muthén and Muthén, 
1998–2010). Mplus can produce maximum likelihood estimations under missing at random 
conditions. Model fit was evaluated based on conventional fit statistics, including χ2, 
Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), and root mean square error of 
approximation (RMSEA). The following cutoffs were used to identify good-to-excellent 
model fit: CFI ≥ .95, TLI ≥ .95, and RMSEA ≤ .06 (Hu and Bentler, 1999). We also 
conducted χ2 difference tests for nested models (using the DIFFTEST option in Mplus) to 
evaluate which model provided the best representation of the symptom structure of PTSD 
after suspected ACS.
Second, we examined whether the best-fitting model was invariant by sex using a 
comprehensive invariance testing approach (Meredith and Teresi, 2006). We tested a series 
of models that imposed increasingly stringent restrictions across men and women: 1) 
Configural invariance model (same factor structure across groups but all parameters allowed 
to vary); 2) Weak factorial/metric invariance model (factor loadings constrained to be equal 
across groups); 3) Strong factorial/scalar invariance model (observed variable thresholds 
constrained to be equal across groups to assess equivalence in item severity); 4) Strict 
factorial invariance model (residual error variances constrained to be equal across groups to 
assess equivalence in measurement error across groups); 5) Invariance of factor variances 
and covariances (factor variances and covariances constrained to be equal across groups); 
and 6) Invariance of factor means (factor means constrained to be equal across groups). We 
investigated whether each of the progressively more restricted models was associated with a 
statistically significant decrement in model fit using χ2 difference tests (using the 
DIFFTEST option in Mplus). Two participants were missing data on sex and were excluded 
from tests of measurement invariance across sex, resulting in sub-samples of 212 men and 
185 women.
Third, using a latent variable framework, we examined correlates of the suspected ACS-
related PTSD symptom dimensions by correlating PTSD dimensions from the best-fitting 
model with a factor representing perceived life threat and personal vulnerability in the ED 
(defined by the 12 items administered in the ED) and an indicator representing 100% aspirin 
adherence in the month after ACS evaluation. We assessed differences in the magnitude of 
these correlations by computing Wald χ2 tests of parameter constraints (Muthén and 
Muthén, 1998–2010). Wald tests were computed to assess whether the difference between 
each pair of correlations was statistically significantly different than zero.
3. Results
3.1 Descriptive Statistics
Descriptive statistics are presented in Table 1. Men (M=24.67, SD=6.69) and women 
(M=25.31, SD=7.13) reported similar mean levels of perceived life threat and personal 
vulnerability in the ED, t(395)=0.92, p=.36. Although all participants presented to the ED 
with acute cardiac symptoms consistent with probable ACS according to the treating ED 
physician’s determination, only 34.1% were diagnosed with ACS at hospital discharge based 
on medical record review. The remaining participants were given diagnoses such as chest 
pain without a cardiac diagnosis, another symptom/disease process (e.g., hypertensive 
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chronic kidney disease, Tietze’s disease), or another cardiac disease (e.g., intermediate 
coronary syndrome). Neither perceived life threat and personal vulnerability in the ED nor 
PTSD total severity scores (calculated by summing the responses to the PCL-S administered 
at one-month follow-up) differed by confirmed ACS status, ps>.32. Men (M=24.10, 
SD=10.05) and women (M=24.56, SD=10.71) did not differ significantly in their mean 
PTSD severity scores, t(395)=0.44, p=.66. The percentages of men (15.6%) and women 
(16.2%) with a positive screen for probable PTSD (PCL-S≥35) also did not differ 
significantly, χ2(1)=0.03, p=.86. The majority of participants reported at one-month follow-
up that their doctor had recommended that they take aspirin, and most of those individuals 
endorsed full adherence in the past month. A higher percentage of men (90.2%) than women 
(78.4%) reported 100% aspirin adherence, χ2(1)=7.73, p=.01.
3.2 Model Fit Comparison
Fit statistics for the 4- and 5-factor models are presented in Table 3. All models fit the PCL-
S data well. Chi-square difference tests indicated that the 5-factor dysphoric arousal model 
fit significantly better than the 4-factor numbing model [χ2(4) = 12.44, p = .01] but not 
significantly better than the 4-factor dysphoria model [χ2(4) = 3.59, p = .46]. Thus, based on 
model fit statistics and parsimony, we selected the 4-factor dysphoria model as the best-
fitting model of PTSD symptoms after suspected ACS.
3.3 Measurement Invariance by Sex
Factorial invariance testing results are presented in Table 4. Fit statistics for models with 
constraints at the different levels tested indicated very good fit to the data. There was 
evidence of measurement invariance in factor loadings, item thresholds, residual error 
variances, factor variances and covariances, and factor means for the dysphoria model 
across men and women. Chi-square difference tests comparing nested models suggested that 
constraining these different parameters to be equal across sex was not associated with 
statistically significant decrements in model fit. Together, these results supported invariance 
in the meaning of the PTSD factors, item severity, residual error, factor score variation, 
correlations between the PTSD factors, and latent mean scores across men and women.
3.3 Correlates of PTSD Symptom Dimensions
Table 5 presents the intercorrelations of the factors of the dysphoria model and Table 6 
presents correlations between the PTSD symptom dimensions with a factor representing 
perceived life threat and personal vulnerability in the ED and an indicator representing 
100% aspirin adherence in the month after ACS evaluation. Consistent with the broader 
literature on the latent structure of PTSD (e.g., Sumner et al., 2014; Wang et al., 2011), the 
PTSD symptom dimensions were highly correlated with one another. Despite these high 
correlations, the relative distinctiveness of the PTSD symptom dimensions was suggested by 
differential strength of associations between the dimensions with indicators of PTSD risk 
and cardiovascular health. Specifically, re-experiencing and dysphoria symptoms had the 
largest positive correlations with perceived life threat and personal vulnerability in the ED, 
whereas avoidance symptoms had the smallest positive correlation with this ED predictor. 
Results of the Wald tests indicated that the re-experiencing-perceived threat and dysphoria-
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perceived threat correlations were significantly larger than the corresponding correlations 
with avoidance. We investigated what might be driving the dysphoria-perceived threat 
correlation by examining correlations between perceived threat with separate factors defined 
by the five numbing items of the dysphoria dimension (e.g., loss of interest, feeling as if the 
future will be cut short) and by the three dysphoric arousal items of the dysphoria dimension 
(e.g., trouble falling or staying asleep, irritability). The numbing-perceived threat correlation 
(r=.535, p<.0001) was larger than the dysphoric arousal-perceived threat correlation (r=.
455, p<.0001), although the difference in magnitude was not statistically significant, Wald 
test(1)=3.491, p=.062. Moreover, only the numbing-perceived threat correlation was 
significantly larger than the avoidance-perceived threat correlation [comparison for 
numbing: Wald test (1)=6.749, p=.009; comparison for dysphoric arousal: Wald test 
(1)=1.684, p=.194].
The re-experiencing-aspirin adherence correlation was the smallest in magnitude for this 
correlate; re-experiencing symptoms were the only dimension that was not significantly 
negatively correlated with 100% aspirin adherence at one-month follow-up. Results of the 
Wald tests suggested that the avoidance-aspirin adherence and dysphoria-aspirin adherence 
correlations were larger than the re-experiencing-aspirin adherence correlation, although 
these tests were not statistically significant (ps<.08). As above, we further probed the 
dysphoria-aspirin adherence association by computing separate correlations for the numbing 
and dysphoric arousal symptoms of the dysphoria dimension. The numbing-aspirin 
adherence correlation (r=−.266, p=.006) and dysphoric arousal-aspirin adherence correlation 
(r=−.256, p=.011) were similar in magnitude, Wald test(1)=0.013, p=.911. Neither 
correlation was significantly larger than the re-experiencing-aspirin adherence correlation 
[comparison for numbing: Wald test (1)=2.426, p=.119; comparison for dysphoric arousal: 
Wald test (1)=2.294, p=.130].
4. Discussion
In recent years, acute life-threatening medical events have received increasing attention as 
traumatic events that can induce PTSD symptoms (see Edmondson, 2014, for a review). 
However, the extant literature has generally treated PTSD as a dichotomous diagnosis or 
total symptom score, which fails to capture the heterogeneous clinical manifestation of this 
disorder. In this first known examination of the dimensional structure of PTSD after an acute 
medical event, we found that the 4-factor dysphoria model provided the best representation 
of PTSD symptoms after suspected ACS. There was strong evidence of measurement 
invariance of the dysphoria model by sex. Moreover, findings suggested that the symptom 
dimensions of the dysphoria model had differential strengths of associations with variables 
with relevance to PTSD risk—perceived life threat and personal vulnerability in the ED—as 
well as cardiovascular health—post-discharge aspirin adherence, which provides support for 
the distinctiveness of these dimensions and their external validity.
As is common in the literature on the dimensional structure of PTSD symptoms (e.g., 
Armour et al., 2013; Sumner et al., 2014), the dysphoria, numbing, and dysphoric arousal 
models all fit the data well. However, we identified the dysphoria model as the best-fitting 
model based on fit statistics and parsimony. The dysphoria model distinguishes between 
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specific (i.e., re-experiencing, active avoidance, hypervigilance, exaggerated startle) and 
non-specific (i.e., dysphoria) symptoms of PTSD, and it has received substantial support in 
the broader PTSD literature (Yufik and Simms, 2010). Whereas symptoms more closely 
related to fear responses (e.g., re-experiencing, exaggerated startle) are thought to represent 
core aspects of PTSD, non-specific symptoms of dysphoria and general distress are also 
characteristic of other psychological symptoms, such as depression and generalized anxiety 
(Simms et al., 2002; Zoellner et al., 2014).
We believe that our findings can help to inform the conceptualization of PTSD triggered by 
an acute life-threatening medical event. Some researchers have questioned whether PTSD 
that develops after a traumatic experience like ACS or cancer is qualitatively distinct from 
PTSD triggered by a discrete external trauma, such as combat exposure or a natural disaster 
(see Edmondson, 2014, for a review). Our results indicated that the DSM-IV PTSD 
symptoms that developed in response to suspected ACS exhibited a similar structure to the 
same symptoms induced by other traumatic experiences (e.g., military experiences; Simms 
et al., 2002), which suggests that both types of PTSD can be conceptualized within this 
similar framework. Nevertheless, it is possible that differences may emerge between PTSD 
triggered by an acute life-threatening medical event vs. other traumatic events with more 
nuanced assessments (e.g., by assessing ongoing present- and future-oriented intrusions in 
those with medically-induced PTSD given the enduring somatic threat that may exist for 
these individuals; Edmondson, 2014).
We found that the dysphoria model fit well in men and women. Moreover, results suggested 
that men and women did not differ significantly in PTSD factor meaning, item severity, 
residual error, factor score variance, factor intercorrelations, and factor means. This set of 
findings is in contrast to some results from the broader PTSD literature. For example, 
epidemiologic research has found that lifetime PTSD is twice as common in women than in 
men (Kessler et al., 1995), and meta-analytic evidence suggests that women report greater 
PTSD symptom severity than men in response to a variety of traumatic events, although 
acute medical events were not included in this analysis (Tolin and Foa, 2006). Furthermore, 
several studies in the broader PTSD literature have documented sex differences in aspects of 
PTSD factor structure that suggested greater severity for female than male participants (e.g., 
Armour, Elhai et al., 2011; Sumner et al., 2014; Wang et al., 2013). However, our current 
findings of measurement invariance of the dysphoria model across sex are consistent with 
some initial results from research on ACS-induced PTSD. In a meta-analysis of the 
prevalence of PTSD in ACS patients, the percentage of male participants in study samples 
was not significantly associated with PTSD prevalence estimates (Edmondson et al., 2012). 
More research on possible sex differences in the presentation of PTSD triggered by acute 
medical events is needed, but our findings suggest that PTSD symptoms after suspected 
ACS manifested similarly in men and women in our sample.
In addition to elucidating the factor structure of suspected ACS-related PTSD symptoms, we 
examined whether perceived life threat and personal vulnerability, a risk factor for the 
development of PTSD (Holbrook et al., 2001), was differentially associated with PTSD 
symptom dimensions. Although perceived threat/vulnerability was positively correlated with 
all symptom dimensions, greater perceived threat/vulnerability in the ED was a significantly 
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stronger predictor of re-experiencing and dysphoria symptoms than avoidance symptoms. 
This pattern of results is consistent with theoretical and empirical work on the progression of 
PTSD symptoms. Specifically, Creamer et al. (1992) proposed that processing of the 
threatening aspects of a traumatic event contributes to the formation of a fear memory 
network that leads to re-experiencing symptoms, such as intrusions, and that avoidance 
symptoms develop secondarily (and hence, less directly) as a strategy to cope with the re-
experiencing symptoms. We also found that perceived threat/vulnerability in the ED was a 
significantly stronger predictor of dysphoria than avoidance symptoms, which may suggest 
that perceptions of threat in the early stages of an acute cardiac event may be associated with 
experiencing greater levels of non-specific general distress after suspected ACS. 
Alternatively, more general dysphoria also may have preceded the development of PTSD 
and have been a risk factor for PTSD onset (Edmondson et al., 2014). Furthermore, results 
suggested that the numbing symptoms of dysphoria (e.g., loss of interest, feeling as if the 
future will be cut short) were especially related to perceived threat in the ED. There was a 
trend for the association between perceived threat in the ED with numbing symptoms to be 
stronger than the corresponding correlation with dysphoric arousal symptoms, and the 
numbing-perceived threat correlation was significantly larger than the avoidance-perceived 
threat correlation. Thus, a heightened sense of personal vulnerability in the acute aftermath 
of suspected ACS may underlie, in part, the development of symptoms of emotional 
withdrawal and disengagement. Qualitative interviews with patients may help to better 
understand how these particular aspects of PTSD develop after suspected ACS.
We also examined associations between PTSD symptom dimensions and aspirin adherence 
at one-month follow-up (Kronish, Edmondson et al., 2012). Of the four dimensions of the 
dysphoria model, re-experiencing symptoms evidenced the smallest correlation with 
complete aspirin adherence in the past month, and there were trends for the negative 
correlations between avoidance and dysphoria symptoms with aspirin adherence to be larger 
than the corresponding correlation for re-experiencing symptoms. In addition, both the 
numbing and dysphoric arousal aspects of the dysphoria dimension were similarly related to 
poor aspirin adherence. Even though the differences between the re-experiencing, 
avoidance, and dysphoria associations with aspirin adherence were not statistically 
significant, they provide a preliminary indication that avoidance and dysphoria (but not re-
experiencing) symptoms may be particularly important for understanding why some patients 
with suspected ACS-related PTSD symptoms do not follow through with the 
recommendations of their doctors to manage their health conditions. Ultimately, 
investigating how the underlying dimensions of PTSD after suspected ACS relate to 
functional correlates relevant to cardiovascular health may help to inform the development 
of more targeted and efficient intervention efforts. For example, if our initial findings 
receive further support in subsequent research, then it is possible that individuals with high 
avoidance and dysphoria symptoms might benefit most from approach-oriented 
interventions that incorporate behavioral activation and problem-solving techniques (e.g., 
Katon et al., 2010), which may reduce avoidance and withdrawal behaviors and encourage 
engagement with health management strategies (e.g., Katon et al., 1996; Lin et al., 2012; 
also see Kronish, Rieckmann et al., 2012).
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Four methodological limitations need to be acknowledged. First, although all participants 
were recruited during evaluation for ACS in the ED, nearly two-thirds of the sample was not 
diagnosed with ACS at discharge. This finding is consistent with results from other studies 
in which patients were recruited for suspected ACS in the ED (e.g., rates of confirmed ACS 
have ranged from 16–30% in recent studies; Chase et al., 2006; Kwong et al., 2003). 
Additionally, the non-ACS diagnoses were perceived as equally threatening and painful as 
confirmed ACS diagnoses. Furthermore, we assessed PTSD symptoms in response to the 
suspected ACS and related hospitalization that occurred when participants enrolled in the 
study. Thus, our work provides a broad perspective on PTSD symptoms that develop in 
response to suspected ACS, and it can serve as a foundation for more targeted research. 
Second, as in other work on PTSD factor structure, some factors were defined by only two 
items. Ideally, more indicators are used to define a latent construct in order to produce more 
reliable factors and stable parameter estimates (Marsh et al., 1998). It is also of interest to 
characterize these dimensions of PTSD across units of analysis that go beyond self-report, 
such as neural, physiological, and behavioral levels. Third, because this study was initiated 
before the DSM-5 was published, our findings reflect the underlying dimensions of PTSD as 
defined by DSM-IV. Although changes were made in revising the PTSD diagnostic criteria 
from DSM-IV to DSM-5 (e.g., the removal of the subjective fear/helplessness/horror 
Criterion A2; the addition of symptoms of persistent blame, persistent negative emotional 
state, and reckless/destructive behavior), most of the DSM-5 and DSM-IV PTSD criteria are 
highly similar. Moreover, a 4-factor model of PTSD symptoms was included in the DSM-5. 
Nevertheless, further research is needed to investigate whether the dysphoria model provides 
a good fit to the DSM-5 PTSD symptoms that develop after suspected ACS. Fourth, our data 
on aspirin adherence were based on self-report, and future work on this topic should include 
objective measures of adherence, such as electronic pill bottle monitors, as a way to 
overcome potential reporting biases. Moreover, data on aspirin adherence and PTSD 
symptoms were both assessed at one-month follow-up, so additional longitudinal research is 
needed to delineate temporal associations.
Despite these limitations, we believe that our study is characterized by several strengths that 
extend the extant literature on the dimensional structure of PTSD symptoms. Specifically, 
whereas most work on the dimensional structure of PTSD has been conducted in military 
samples (e.g., Harpaz-Rotem et al., 2014; King et al., 1998; Simms et al., 2002) or natural 
disaster victims (e.g., Sumner et al., 2014; Wang et al., 2011), we recruited patients from the 
ED during evaluation for ACS. Moreover, in this racially and ethnically diverse sample, we 
not only tested measurement invariance by sex but we also examined differential 
associations with correlates related to risk for developing PTSD and subsequent adherence 
to cardioprotective medication.
3.2 Conclusions
ACS-related PTSD represents a substantial proportion of the PTSD burden in developed 
countries, and it has been estimated that over 150,000 ACS patients in the United States will 
develop PTSD symptoms in a given year (Edmondson, 2014). Our results suggest that 
considering underlying dimensions of PTSD, rather than treating PTSD as a homogenous 
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diagnostic entity, may help inform assessment and intervention efforts to promote emotional 
and cardiovascular health after suspected ACS. Longitudinal studies that examine the course 
of these dimensions are needed to better characterize these symptom dimensions and how 
they relate to aspects of emotional and physical functioning over time. Most importantly, 
future research should examine whether particular dimensions of PTSD are especially 
predictive of ACS recurrence and all-cause mortality.
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• PTSD symptoms induced by acute coronary syndrome (ACS) are common (12% 
prevalence).
• We evaluated the dimensional structure of PTSD after suspected ACS.
• A 4-factor dysphoria model with specific and non-specific PTSD symptoms fit 
best.
• There was evidence of measurement invariance of this model by sex.
• PTSD dimensions related differentially to perceived threat and aspirin 
adherence.
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Table 1
Participant characteristics, N=399.




 White 32.3% (129)
 Black/African American 23.1% (92)
 Other 44.6% (178)
Hispanic ethnicity 51.4% (205)
High school degree or greater 64.2% (256)
Age 61.1 years (12.6) 27–95 years
Hospital Assessment
Perceived life threat and personal vulnerability total score in the ED 24.96 (6.89) 12–46
Confirmed ACS upon discharge 34.1% (136)
One-month Follow-up Assessment
PTSD total severity scorea 24.30 (10.33) 17–76
Positive screen for probable PTSDb 15.8% (63)
Aspirin recommended by doctor 71.4% (285)
 Reported 100% adherence to aspirin in the past monthc 85.6% (244)
Note. ED = emergency department. ACS = acute coronary syndrome.
a
PTSD total severity score calculated by summing responses on the PTSD Checklist for a Specific Stressful Experience (PCL-S).
b
Positive screen based on a cut-off of total PCL-S scores greater than or equal to 35.
c
Percentage is for those participants who reported that their doctor recommended aspirin.
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Table 2
Item mappings of the dysphoria, numbing, and dysphoric arousal models.
DSM-IV PTSD symptom Item Mappings
Dysphoria Numbing Dysphoric Arousal
B1. Intrusive thoughts of trauma R R R
B2. Recurrent dreams of trauma R R R
B3. Flashbacks R R R
B4. Emotional reactivity to trauma cues R R R
B5. Physiological reactivity to trauma cues R R R
C1. Avoiding thoughts of trauma A A A
C2. Avoiding reminders of trauma A A A
C3. Inability to recall aspects of trauma D N N
C4. Loss of interest D N N
C5. Detachment D N N
C6. Restricted affect D N N
C7. Sense of foreshortened future D N N
D1. Sleep disturbance D H DA
D2. Irritability D H DA
D3. Difficulty concentrating D H DA
D4. Hypervigilance H H AA
D5. Exaggerated startle response H H AA
Note. DSM-IV = Diagnostic and Statistical manual of Mental Disorders, 4th edition. R = re-experiencing; A = avoidance; H = hyperarousal; D = 
dysphoria; N = numbing; DA = dysphoric arousal; AA = anxious arousal.
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Table 5
Correlations between the factors of the dysphoria model.
1. 2. 3. 4.
1. Re-experiencing (.821)
2. Avoidance .881 (.608)
3. Dysphoria .878 .816 (.855)
4. Hyperarousal .762 .774 .921 (.635)
Note. Coefficients in parentheses along the diagonal are Cronbach’s alpha coefficients.
All ps < .0001
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